DNA testing company 23andMe has partnered with pharmaceutical giant GlaxoSmithKline (GSK), in a bid to develop new drug treatments. 23andMe, which gives customers insight into their genetic makeup via postal saliva tests, has some five million custom...
GSK to use 23andMe’s DNA library in drug development
DNA testing company 23andMe has partnered with pharmaceutical giant GlaxoSmithKline (GSK), in a bid to develop new drug treatments. 23andMe, which gives customers insight into their genetic makeup via postal saliva tests, has some five million custom...
Developing a new drug is a long, complicated and expensive process that takes years before you get to the human trial. There's a hope that computers will be able to simulate the majority of the process, greatly reducing the cost and time involved. Th...
By forcing startups like Google X, Fiber and Nest to behave like companies and take financial accountability, Alphabet believes that its subsidiaries are more likely to invest in projects that will ultimately make it money. Being in the expensive hea...
Although Apple's ResearchKit is almost two years old, the platform has mainly been reserved for clinical studies hosted by universities and medical researchers. Hundreds of thousands of people are already contributing data for studies focusing on ast...
